​​Finally, a full line wholesaler that works for you!

(b) ​The registrant shall design and operate a system to disclose to the registrant suspicious orders of controlled substances. The registrant shall inform the Field Division Office of the Administration in his area of suspicious orders when discovered by the registrant. Suspicious orders include orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency. ​

Contact Us

For more information about our Programs and Services 

Our Compliance Department actively monitors all orders for controlled substances that are passed through our SOM (Suspicious Order Monitoring) program after being submitted to Value.  Any order that is deemed suspicious or ‘an order of interest’ is then suspended by our ordering system.  This order cannot be released to the store until it has been determined to not be suspicious. 

This checks and balances system serves a two fold purpose: 1) It allows Value to fulfill our obligations under the above stated guideline and 2) It helps us help you, through guidance from our controlled substance compliance staff, to validate that you are using the appropriate due diligence when dispensing controlled substances and ensuring that the prescription being filled is for a legitimate medical purpose.

We work closely with our members through the process who can find more information and program requirements on

As a distributor of controlled substances registered with the Drug Enforcement Administration (DEA), Value Drug Company is required to follow the DEA’s Office of Diversion Control regulations under Title 21 CFR 1301.74(b).

CONTROLLED SUBSTANCE: Suspicious order monitoring Program